Clinical trials
Recruiting Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Instituto do Cancer do Estado de São Paulo | 2 |
| Columbia University | 1 |
| Instituto Nacional de Cancer, Brazil | 1 |
| Nelson Hamerschlak | 1 |
| Novartis Pharmaceuticals | 1 |
| University of Sao Paulo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Lymphoma, Non-Hodgkin | 2 |
| Congenital Microtia | 1 |
| Genetic Predisposition to Disease | 1 |
| Graft vs Host Disease | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma | 1 |
| Lymphoma, Follicular | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.